Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, U.S.A.
Department of Cell and Developmental Biology, University of Colorado School of Medicine, Aurora, CO 80045, U.S.A.
Biochem Soc Trans. 2020 Feb 28;48(1):231-243. doi: 10.1042/BST20190597.
The planar cell polarity (PCP) signaling pathway is a potent developmental regulator of directional cell behaviors such as migration, asymmetric division and morphological polarization that are critical for shaping the body axis and the complex three-dimensional architecture of tissues and organs. PCP is considered a noncanonical Wnt pathway due to the involvement of Wnt ligands and Frizzled family receptors in the absence of the beta-catenin driven gene expression observed in the canonical Wnt cascade. At the heart of the PCP mechanism are protein complexes capable of generating molecular asymmetries within cells along a tissue-wide axis that are translated into polarized actin and microtubule cytoskeletal dynamics. PCP has emerged as an important regulator of developmental, homeostatic and disease processes in the respiratory system. It acts along other signaling pathways to create the elaborately branched structure of the lung by controlling the directional protrusive movements of cells during branching morphogenesis. PCP operates in the airway epithelium to establish and maintain the orientation of respiratory cilia along the airway axis for anatomically directed mucociliary clearance. It also regulates the establishment of the pulmonary vasculature. In adult tissues, PCP dysfunction has been linked to a variety of chronic lung diseases such as cystic fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary arterial hypertension, stemming chiefly from the breakdown of proper tissue structure and function and aberrant cell migration during regenerative wound healing. A better understanding of these (impaired) PCP mechanisms is needed to fully harness the therapeutic opportunities of targeting PCP in chronic lung diseases.
平面细胞极性 (PCP) 信号通路是一种强大的发育调节因子,可调节定向细胞行为,如迁移、不对称分裂和形态极化,这些行为对于塑造身体轴和组织器官的复杂三维结构至关重要。PCP 被认为是非经典 Wnt 途径,因为在经典 Wnt 级联中观察到的β-连环蛋白驱动的基因表达缺失的情况下,Wnt 配体和 Frizzled 家族受体参与其中。PCP 机制的核心是能够在组织广泛的轴线上在细胞内产生分子不对称性的蛋白质复合物,这些不对称性被转化为极化的肌动蛋白和微管细胞骨架动力学。PCP 已成为呼吸系统发育、稳态和疾病过程的重要调节因子。它与其他信号通路一起作用,通过控制分支形态发生过程中细胞的定向突起运动,来创建肺的复杂分支结构。PCP 在气道上皮细胞中发挥作用,以建立和维持呼吸道纤毛沿着气道轴的方向,以进行解剖定向的黏液纤毛清除。它还调节肺血管系统的建立。在成人组织中,PCP 功能障碍与各种慢性肺部疾病有关,如囊性纤维化、慢性阻塞性肺疾病和特发性肺动脉高压,主要源于组织结构和功能的破坏以及再生性伤口愈合过程中的异常细胞迁移。需要更好地了解这些(受损)PCP 机制,以充分利用靶向慢性肺部疾病中 PCP 的治疗机会。